|
FAM91A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.242400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.168040E-02 |
| Normal-vs-Stage2 |
3.189800E-02 |
| Normal-vs-Stage3 |
1.177800E-03 |
| Normal-vs-Stage4 |
2.034600E-04 |
| Stage1-vs-Stage2 |
8.353400E-01 |
| Stage1-vs-Stage3 |
1.340620E-01 |
| Stage1-vs-Stage4 |
4.663700E-02 |
| Stage2-vs-Stage3 |
4.247200E-01 |
| Stage2-vs-Stage4 |
1.657160E-01 |
| Stage3-vs-Stage4 |
4.640600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.176500E-03 |
| Normal-vs-AfricanAmerican |
2.001000E-01 |
| Normal-vs-Asian |
6.455400E-03 |
| Caucasian-vs-AfricanAmerican |
4.229000E-01 |
| Caucasian-vs-Asian |
7.206600E-01 |
| AfricanAmerican-vs-Asian |
3.477200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.794200E-04 |
| Normal-vs-Female |
7.620200E-03 |
| Male-vs-Female |
1.457760E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.291600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.817500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.298200E-03 |
| Normal-vs-Age(81-100Yrs) |
3.260800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.620300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.951030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.617400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.200800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.921000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.995000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.410200E-01 |
| Classical-VS-Follicular |
3.207400E-01 |
| Classical-VS-Other |
2.386600E-01 |
| Classical-VS-Normal |
1.436010E-02 |
| Tall-VS-Follicular |
7.980600E-01 |
| Tall-VS-Other |
5.252000E-01 |
| Tall-VS-Normal |
1.384210E-02 |
| Follicular-VS-Other |
4.476000E-01 |
| Follicular-VS-Normal |
7.737200E-03 |
| Other-VS-Normal |
2.795600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.825400E-04 |
| Normal-vs-N1 |
1.621550E-03 |
| N0-vs-N1 |
6.278800E-01 |
|
|
